Managing type 2 diabetes mellitus may require a combination of medication, healthy eating, physical activity and regular blood glucose monitoring. When combination therapy is appropriate, healthcare professionals may prescribe medicines containing two active ingredients that work through complementary mechanisms.
Sitacure-M 50/500 is an oral antidiabetic combination medicine containing Sitagliptin 50mg and Metformin Hydrochloride 500mg. It may be prescribed to help improve blood glucose control in adults with type 2 diabetes as part of an overall treatment plan.
Understanding the Sitacure-M 50/500 dosage and uses, how the medicine works and the precautions associated with treatment can help patients use their medication responsibly.
What Is Sitacure-M 50/500?
Sitacure-M 50/500 is an oral antidiabetic medicine containing two active ingredients:
Sitagliptin 50mg
Metformin Hydrochloride 500mg
The therapeutic area is type 2 diabetes, and the medicine is administered orally.
Sitagliptin and Metformin belong to different classes of antidiabetic medicines. Their complementary actions help regulate blood glucose through different pathways.
Treatment should be used together with the diet, physical activity and monitoring recommended by a qualified healthcare professional.
Composition of Sitacure-M 50/500
Each Sitacure-M 50/500 tablet contains:
Sitagliptin 50mg
Sitagliptin is a DPP-4 inhibitor. It helps regulate blood glucose through incretin-related pathways and supports glucose-dependent insulin release while reducing glucagon secretion.
Metformin Hydrochloride 500mg
Metformin is a biguanide medicine. It primarily reduces glucose production by the liver and also improves the body's response to insulin.
Sitacure-M 50/500 Uses
The main Sitacure-M 50/500 use is to support blood glucose control in adults with type 2 diabetes mellitus when combination treatment with Sitagliptin and Metformin is considered appropriate.
It may form part of a comprehensive diabetes management plan that includes:
Appropriate dietary changes
Regular physical activity
Blood glucose monitoring when recommended
Regular medical consultations
Prescribed diabetes medication
The medicine is not intended to replace healthy lifestyle measures. A healthcare professional should determine whether this combination is suitable based on the patient's individual condition.
How Does Sitacure-M 50/500 Work?
The two active ingredients in Sitacure-M 50/500 work through complementary mechanisms.
Sitagliptin
Sitagliptin inhibits the DPP-4 enzyme, helping incretin hormones remain active for longer. This supports glucose-dependent insulin release and helps reduce glucagon secretion when blood glucose levels are elevated.
Metformin
Metformin primarily decreases glucose production by the liver. It also improves insulin sensitivity, helping the body use glucose more effectively.
By combining these mechanisms, Sitacure-M 50/500 may help support improved glycaemic control when appropriately prescribed.
Sitacure-M 50/500 Dosage and Administration
The appropriate Sitacure-M 50/500 dosage should always be determined by a qualified healthcare professional. The prescribed regimen may depend on several factors, including previous diabetes treatment, blood glucose control, kidney function, tolerability and other medical conditions.
Sitagliptin and Metformin combination medicines are generally administered with meals. Patients should follow the exact instructions provided by their doctor or pharmacist.
Do not increase, decrease or discontinue the prescribed dose without consulting your healthcare professional.
If a dose is missed, patients should follow the instructions provided by their doctor or pharmacist rather than taking an additional dose without professional advice.
Potential Benefits of Sitacure-M 50/500
When appropriately prescribed, Sitacure-M 50/500 may offer several potential advantages as part of type 2 diabetes management:
Combines Sitagliptin 50mg and Metformin 500mg in one tablet
Provides complementary mechanisms for blood glucose regulation
May help improve glycaemic control
Can form part of an overall type 2 diabetes treatment plan
Treatment response can vary between individuals, so regular follow-up with a healthcare professional is important.
Possible Side Effects
Like other medicines, Sitacure-M 50/500 may cause side effects in some patients. Gastrointestinal symptoms may occur, particularly with Metformin-containing treatment.
Possible side effects include:
Nausea
Diarrhoea
Stomach discomfort
Headache
Reduced appetite
Patients should contact their doctor or healthcare professional if symptoms are severe, persistent or unusual.
Warnings and Precautions
Before starting Sitacure-M 50/500, patients should inform their healthcare professional about their medical history and all prescription medicines, non-prescription medicines, vitamins and dietary supplements they are taking.
Particular attention may be required in people with kidney problems, liver disease, heart conditions or a history of pancreatitis.
Kidney Function
Kidney function is an important consideration when using Metformin-containing medicines. Renal function should be assessed and monitored as clinically appropriate.
Pancreatitis
Acute pancreatitis has been reported with Sitagliptin-containing medicines. Seek medical advice if severe or persistent abdominal pain develops.
Lactic Acidosis
Metformin is associated with a rare but serious risk of lactic acidosis. Certain conditions, including significant renal impairment, may increase this risk. Follow medical advice carefully and seek professional attention if concerning symptoms occur.
Drug Interactions
Patients should inform their doctor or pharmacist about all medicines, vitamins and dietary supplements they currently use. Certain medicines may affect blood glucose levels, kidney function or the safety of diabetes treatment.
A healthcare professional can determine whether additional monitoring or treatment adjustment is necessary.
Storage Information
Store Sitacure-M 50/500 according to the conditions stated on the product packaging.
Protect from excessive heat and moisture.
Keep away from direct sunlight.
Keep the medicine in its original packaging.
Keep out of reach of children.
Frequently Asked Questions About Sitacure-M 50/500
What is Sitacure-M 50/500?
Sitacure-M 50/500 is an oral antidiabetic combination tablet containing Sitagliptin 50mg and Metformin Hydrochloride 500mg. It is used as part of a treatment plan for adults with type 2 diabetes mellitus.
What is the composition of Sitacure-M 50/500?
Each tablet contains Sitagliptin 50mg and Metformin Hydrochloride 500mg.
What is Sitacure-M 50/500 used for?
Sitacure-M 50/500 may be prescribed to help improve blood glucose control in adults with type 2 diabetes mellitus when combination treatment is considered appropriate.
How does Sitacure-M 50/500 work?
Sitagliptin is a DPP-4 inhibitor, while Metformin is a biguanide. The two medicines work through complementary mechanisms involved in blood glucose regulation.
What are the possible side effects?
Possible side effects may include nausea, diarrhoea, stomach discomfort, headache and reduced appetite. Consult a healthcare professional if symptoms are severe or persistent.
How should Sitacure-M 50/500 be taken?
Follow the dosage and administration instructions provided by your doctor or pharmacist. Do not change the prescribed dose without professional medical advice.
Medical Disclaimer
The information provided in this article is for general educational and informational purposes only. It is not intended to replace professional medical advice, diagnosis or treatment.
Sitacure-M 50/500 should be used only as directed by a qualified healthcare professional. Always refer to approved product information and consult your doctor or pharmacist for individual medical advice.
